A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT02763319 · COMPLETED
Trial details
- NCT number
- NCT02763319
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2024-06-21
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.